In summary, the present review reported irisin may represent a novel PCOS biomarker and might directly contribute to the etiology of PCOS or indirectly affect the development of disordered metabolism (such as obesity, hyperandrogenism, impaired glucose tolerance, and insulin resistance) in PCOS [58]. This evidence concerns the gene FNDC5 and hyperandrogenism.